X-ray fluorescence microprobe imaging in biology and medicine

Journal of Cellular Biochemistry

Volumn 99, Issue 6, 2006, Pages 1489-1502

  Paunesku, Tatjana ^a   Vogt, Stefan ^b   Maser, Jörg ^b   Lai, Barry ^b   Woloschak, Gayle ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bionanotechnology; Elemental maps; Metalome; X ray fluorescence microscopy

Indexed keywords

ALUMINUM; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTILEISHMANIAL AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; ARSENIC; BINDING PROTEIN; CADMIUM; CALCIUM; CHLORINE; CHROMIUM; COPPER; DNA; IRON; LEAD; MANGANESE; MERCURY; METAL; NICKEL; PHOSPHORUS; POTASSIUM; SULFUR; TITANIUM; TITANIUM DIOXIDE; TRACE ELEMENT; VANADIUM; ZINC;

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BIOLOGY; BIOTECHNOLOGY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; CELL DIFFERENTIATION; CELL ORGANELLE; CELL STRAIN HL 60; CELLULAR DISTRIBUTION; CHEMICAL CARCINOGENESIS; CIGARETTE SMOKING; DIETARY INTAKE; DRUG TRANSFORMATION; ENVIRONMENTAL EXPOSURE; ESOPHAGUS CANCER; FLUORESCENCE MICROSCOPY; GENETIC ENGINEERING; HEAVY METAL POISONING; HOST PATHOGEN INTERACTION; HUMAN; IMAGING SYSTEM; IMPLANT; LEISHMANIASIS; MALARIA; MARINE ENVIRONMENT; MEDICAL TECHNOLOGY; MENKES SYNDROME; METAL BINDING; MITOCHONDRION; MOLECULAR IMAGING; MUTAGENESIS; NANOTECHNOLOGY; NEUROPATHOLOGY; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS; REVIEW; SQUAMOUS CELL CARCINOMA; STEM CELL; SYNCHROTRON; TISSUE DISTRIBUTION; TUBERCULOSIS; WILSON DISEASE; X RAY FLUORESCENCE; X RAY FLUORESCENCE MICROSCOPY; X RAY MICROANALYSIS;

ANIMALS; HOMEOSTASIS; HUMANS; METALS; MICROSCOPY, FLUORESCENCE; NANOTECHNOLOGY; THERAPEUTICS; TRACE ELEMENTS;

EID: 33751561930     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21047     Document Type: Review

References (107)

1. Abnet CC, Lai B, Qiao YL, Vogt S, Luo XM, Taylor PR, Dong ZW, Mark SD, Dawsey SM. 2005. Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst 97:301-306.
2. Abrams SA. 2003. Normal acquisition and loss of bone mass. Horm Res 60 Suppl 3:71-76.
3. Blute NK, Brabander DJ, Hemond HF, Sutton SR, Newville MG, Rivers ML. 2004. Arsenic sequestration by ferric iron plaque on cattail roots. Environ Sci Technol 38:6074-6077.
4. Boyd PW, Law CS, Wong CS, Nojiri Y, Tsuda A, Levasseur M, Takeda S, Rivkin R, Harrison PJ, Strzepek R, Gower J, McKay M, Abraham E, Arychuk M, Barwell-Clarke J, Crawford W, Crawford D, Hale M, Harada K, Johnson K, Kiyosawa H, Kudo I, Marchetti A, Miller W, Needoba J, Nishioka J, Ogawa H, Page J, Robert M, Saito H, Sastri A, Sherry N, Soutar T, Sutherland N, Taira Y, Whitney F, Wong SK, Yoshimura T. 2004. The decline and fate of an iron-induced subarctic phytoplankton bloom. Nature 428:549-553.
5. Brannon-Peppas L, Blanchette JO. 2004. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649-1659.
6. Brownawell AM, Berent S, Brent RL, Bruckner JV, Doull J, Gershwin EM, Hood RD, Matanoski GM, Rubin R, Weiss B, Karol MH. 2005. The potential adverse health effects of dental amalgam. Toxicol Rev 24:1-10.
7. Buss JL, Torti FM, Torti SV. 2003. The role of iron chelation in cancer therapy. Curr Med Chem 10:1021-1034.
8. Campbell A, Smith MA, Sayre LM, Bondy SC, Perry G. 2001. Mechanisms by which metals promote events connected to neurodegenerative diseases. Brain Res Bull 55:125-132.
9. Chang E, Miller JS, Sun J, Yu WW, Colvin VL, Drezek R, West JL. 2005. Protease-activated quantum dot probes. Biochem Biophys Res Commun 334:1317-1321.
10. Choi H, Choi SR, Zhou R, Kung HF, Chen IW. 2004. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Acad Radiol 11:996-1004.
11. Clarkson TW. 2002. The three modern faces of mercury. Environ Health Perspect 110 Suppl 1:11-23.
12. Cobine PA, Ojeda LD, Rigby KM, Winge DR. 2004. Yeast contain a non-proteinaceous pool of copper in the mitochondrial matrix. J Biol Chem 279:14447-14455.
13. Cortizo MC, Fernandez Lorenzo de Mele M. 2004. Cytotoxicity of copper ions released from metal: Variation with the exposure period and concentration gradients. Biol Trace Elem Res 102:129-1241.
14. Croft SL, Coombs GH. 2003. Leishmaniasis - Current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 19:502-508.
15. Cui Z, Lockman PR, Atwood CS, Hsu CH, Gupte A, Allen DD, Mumper RJ. 2005. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases. Eur J Pharm Biopharm 59:263-272.
16. Davidson PW, Myers GJ, Weiss B. 2004. Mercury exposure and child development outcomes. Pediatrics 113:1023-1029.
17. Desoize B. 2003. Metals and metal compounds in carcinogenesis. In Vivo 17:529-539.
18. Dillon CT, Lay PA, Kennedy BJ, Stampfl AP, Cai Z, Ilinski P, Rodrigues W, Legnini DG, Lai B, Maser J. 2002. Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: Intracellular mapping of the biotransformation products of a chromium carcinogen. J Biol Inorg Chem 7:640-645.
19. Dillon CT, Kennedy BJ, Lay PA, Lai B, Cai Z, Stampfl APJ, Ilinski P, Legnini D, Maser J, Rodrigues W, Shea-McCarthy G, Cholewa M. 2003. Implementation of X-ray microscopy and micro-XANES analysis for investigations of the cellular uptake and cellular metabolism of transition metals. J De Physique Iv 104:293-296.
20. Dillon CT, Hambley TW, Kennedy BJ, Lay PA, Weder JE, Zhou Q. 2004. Copper and zinc complexes as antiinflammatory drugs. Met Ions Biol Syst 41:253-277.
21. Doraiswamy PM, Finefrock AE. 2004. Metals in our minds: Therapeutic implications for neurodegenerative disorders. Lancet Neurol 3:431-434.
22. Farrell N. 2002. Biomedical uses and applications of inorganic chemistry. An overview. Coord Chem Rev 232:1-4.
23. Ferguson AD, Deisenhofer J. 2004. Metal import through microbial membranes. Cell 116:15-24.
24. Ferrari M. 2005. Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer 5:161-171.
25. Finney LA, O'Halloran TV. 2003. Transition metal speciation in the cell: Insights from the chemistry of metal ion receptors. Science 300:931-936.
26. Fouillit M, Grillon G, Fritsch P, Rateau G, Pave D, Delforge J, Le Gall B. 2004. Comparative tissue uptake and cellular deposition of three different plutonium chemical forms in rats. Int J Radiat Biol 80:683-689.
27. Fournie GJ, Mas M, Cautain B, Savignac M, Subra JF, Pelletier L, Saoudi A, Lagrange D, Calise M, Druet P. 2001. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun 16:319-326.
28. Fowler BA, Whittaker MH, Lipsky M, Wang G, Chen XQ. 2004. Oxidative stress induced by lead, cadmium and arsenic mixtures: 30-day, 90-day, and 180-day drinking water studies in rats: An overview. Biometals 17:567-568.
29. Frederickson CJ, Koh JY, Bush AI. 2005. The neurobiology of zinc in health and disease. Nat Rev Neurosci 6:449-462.
30. Gassen M, Youdim MB. 1997. The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders. Pharmacol Toxicol 80:159-166.
31. Glesne D, Vogt S, Maser J, Legnini D, Huberman E. 2006. Regulatory properties and cellular redistribution of zinc during macrophage differentiation of human leukemia cells. J Struct Biol 155(1):2-11.
32. Guo ZJ, Sadler PJ. 1999. Metals in medicine. Angewandte Chemie-Int Edn 38:1513-1531.
33. Hall MD, Dillon CT, Zhang M, Beale P, Cai Z, Lai B, Stampfl AP, Hambley TW. 2003a. The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. J Biol Inorg Chem 8:726-732.
34. Hall MD, Dillon CT, Zhang M, Beale P, Cai ZH, Lai B, Stampfl APJ, Hambley TW. 2003b. The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells. J Biol Inorg Chem 8:726-732.
35. Hall MD, Foran GJ, Zhang M, Beale PJ, Hambley TW. 2003c. XANES determination of the platinum oxidation state distribution in cancer cells treated with platinum(IV) anticancer agents. J Am Chem Soc 125:7524-7525.
36. Hall MD, Alderden RA, Zhang M, Beale PJ, Cai Z, Lai B, Stampfl AP, Hambley TW. 2006. The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours. J Struct Biol 155(1):38-44.
37. Hambley TW, Katsifis A, Knott RB, Mattner F, Dikic B. 2002. The structures of imidazenil and iodoimidazenil. Aust J Chem 55:737-739.
38. Harpstrite SE, Beatty AA, Collins SD, Oksman A, Goldberg DE, Sharma V. 2003. Metalloantimalarials: Targeting of P. falciparum strains with novel iron(III) and gallium(III) complexes of an amine phenol ligand. Inorg Chem 42:2294-2300.
39. Harris HH, Levina A, Dillon CT, Mulyani I, Lai B, Cai Z, Lay PA. 2005. Time-dependent uptake, distribution and biotransformation of chromium(VI) in individual and bulk human lung cells: Application of synchrotron radiation techniques. J Biol Inorg Chem 10:105-118.
40. House E, Collingwood J, Khan A, Korchazkina O, Berthon G, Exley C. 2004. Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J Alzheimers Dis 6:291-301.
41. Howe JA, Loeppert RH, DeRose VJ, Hunter DB, Bertsch PM. 2003. Localization and speciation of chromium in subterranean clover using XRF, XANES, and EPR spectroscopy. Environ Sci Technol 37:4091-4097.
42. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. 2004. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci 1012:153-163.
43. Jain KK. 2005. Nanotechnology-based Drug Delivery for Cancer. Technol Cancer Res Treat 4:407-416.
44. Jain KK. 2006. Nanoparticles as targeting ligands. Trends Biotechnol 155(1):143-145.
45. Kehres DG, Maguire ME. 2003. Emerging themes in manganese transport, biochemistry and pathogenesis in bacteria. FEMS Microbiol Rev 27:263-290.
46. Kemner KM, Kelly SD, Lai B, Maser J, O'Loughlin EJ, Sholto-Douglas D, Cai Z, Schneegurt MA, Kulpa CF, Jr., Nealson KH. 2004. Elemental and redox analysis of single bacterial cells by x-ray microbeam analysis. Science 306:686-687.
47. Kicic A, Chua AC, Baker E. 2001. Effect of iron chelators on proliferation and iron uptake in hepatoma cells. Cancer 92:3093-3110.
48. Lai B, Maser J, Paunesku T, Woloschak GE. 2002. Report on the Workshop of Biological Applications of X-ray Microbeams. Int J Radiat Biol 78:749-752.
49. Lai B, Maser J, Vogt S, Paunesku T, Woloschak GE. 2004. Workshop on biological applications of X-ray microscopy and imaging. Advanced Photon Source, Argonne National Laboratory, Argonne, IL, USA, 28-29 April 2003. Int J Radiat Biol 80:459-461.
50. Leonard SS, Bower JJ, Shi X. 2004. Metal-induced toxicity, carcinogenesis, mechanisms and cellular responses. Mol Cell Biochem 255:3-10.
51. Levina A, Turner P, Lay PA. 2003. X-ray absorption spectroscopic studies of chromium nitroso complexes. Crystal and molecular structure of (Ph4P)3[Cr(NO) (NCS)5].2.4(CH3)2CO. Inorg Chem 42:5392-5398.
52. Liu G, Huang W, Moir RD, Vanderburg CR, Lai B, Peng Z, Tanzi RE, Rogers JT, Huang X. 2006. Metal exposure and Alzheimer's pathogenesis. J Struct Biol 155(1):45-51.
53. Magnitsky S, Watson DJ, Walton RM, Pickup S, Bulte JW, Wolfe JH, Poptani H. 2005. In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain. Neuroimage 26:744-754.
54. Martin SF. 2004. T lymphocyte-mediated immune responses to chemical haptens and metal ions: Implications for allergic and autoimmune disease. Int Arch Allergy Immunol 134:186-198.
55. Maser J, Wagner D, Lai B, Cai Z, Legnini D, Moric I, Bermudez L. 2003. Trace metals and their relation to bacterial infections studied by X-ray microscopy. J De Physique Iv 104:283-288.
56. Mather SJ, Britton KE. 2004. Radioimmunotherapy - Progress, potential and problems. Q J Nucl Med Mol Imag 48:248-250.
57. Mautner MN, Conner AJ, Killham K, Deamer DW. 1997. Biological potential of extraterrestrial materials. 2. Microbial and plant responses to nutrients in the Murchison carbonaceous meteorite. Icarus 129:245-253.
58. McRae R, Lai B, Vogt S, Fahrni CJ. 2006. Correlative microXRF and optical immunofluorescence microscopy of adherent cells labeled with ultrasmall gold particles. J Struct Biol 155(1):22-29.
59. Mercer JF. 2001. The molecular basis of copper-transport diseases. Trends Mol Med 7:64-69.
60. Miller TC, Joseph MR, Havrilla GJ, Lewis C, Majidi V. 2003. Capillary electrophoresis micro X-ray fluorescence: A tool for benchtop elemental analysis. Anal Chem 75:2048-2053.
61. Miller LM, Wang Q, Telivala TP, Smith RJ, Lanzirotti A, Miklossy J. 2005. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. J Struct Biol 155(1):30-37.
62. Milligan AJ, Harrison PJ. 2000. Effects of non-steady-state iron limitation on nitrogen assimilatory enzymes in the marine diatom Thalassiosira weissflogii (Bacillariophyceae). J Phycol 36:78-86.
63. Modo M, Mellodew K, Cash D, Fraser SE, Meade TJ, Price J, Williams SC. 2004. Mapping transplanted stem cell migration after a stroke: A serial, in vivo magnetic resonance imaging study. Neuroimage 21:311-317.
64. Morel FM, Price NM. 2003. The biogeochemical cycles of trace metals in the oceans. Science 300:944-947.
65. Mulyani I, Levina A, Lay PA. 2004. Biomimetic oxidation of chromium(III): Does the antidiabetic activity of chromium(III) involve carcinogenic chromium(VI)? Angew Chem Int Ed Engl 43:4504-4507.
66. Mutter J, Naumann J, Sadaghiani C, Schneider R, Walach H. 2004. Alzheimer disease: Mercury as pathogenetic factor and apolipoprotein E as a moderator. Neuro Endocrinol Lett 25:331-339.
67. Oremland RS, Stolz JF. 2003. The ecology of arsenic. Science 300:939-944.
68. Palmer BM, Vogt S, Chen Z, Lachapelle RR, Lewinter MM. 2006. Intracellular distributions of essential elements in cardiomyocytes. J Struct Biol 155(1):12-21.
69. Paunesku T, Rajh T, Wiederrecht G, Maser J, Vogt S, Stojicevic N, Protic M, Lai B, Oryhon J, Thurnauer M, Woloschak G. 2003. Biology of TiO2-oligonucleotide nanocomposites. Nat Mater 2:343-346.
70. Planasbohne F, Duffield J. 1988. Factors Influencing the Uptake of Iron and Plutonium into Cells. Int J Radiat Biol 53:489-500.
71. Redman BG, Esper P, Pan Q, Dunn RL, Hussain HK, Chenevert T, Brewer GJ, Merajver SD. 2003. Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. Clin Cancer Res 9:1666-1672.
72. Reedijk J. 1999. Medicinal applications of heavy-metal compounds. Curr Opin Chem Biol 3:236-240.
73. Reinfelder JR, Fisher NS. 1991. The Assimilation of Elements Ingested by Marine Copepods. Science 251: 794-796.
74. Richardson DR. 2002. Iron chelators as therapeutic agents for the treatment of cancer. Crit Rev Oncol Hematol 42:267-281.
75. Richardson DR. 2004. Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions. Ann N Y Acad Sci 1012:326-341.
76. Rossi L, Lombardo MF, Ciriolo MR, Rotilio G. 2004. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res 29:493-504.
77. Schutz A, Olsson M, Jensen A, Gerhardsson L, Borjesson J, Mattsson S, Skerfving S. 2005. Lead in finger bone, whole blood, plasma and urine in lead-smelter workers: Extended exposure range. Int Arch Occup Environ Health 78:35-43.
78. Schwartz DE, Mancinelli RL, White MR. 1995. Search for life on Mars: Evaluation of techniques. Adv Space Res 15:193-197.
79. Shapiro R, Heaney RP. 2003. Co-dependence of calcium and phosphorus for growth and bone development under conditions of varying deficiency. Bone 32:532-540.
80. Shimura M, Saito A, Matsuyama S, Sakuma T, Terui Y, Ueno K, Yumoto H, Yamauchi K, Yamamura K, Mimura H, Sano Y, Yabashi M, Tamasaku K, Nishio K, Nishino Y, Endo K, Hatake K, Mori Y, Ishizaka Y, Ishikawa T. 2005. Element array by scanning X-ray fluorescence microscopy after cis-diamminedichloro- platinum(II) treatment. Cancer Res 65:4998-5002.
81. Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O. 2004. Iron-source preference of Staphylococcus aureus infections. Science 305:1626-1628.
82. Sparks CJ, Jr. 1980. X-ray fluorescence microprobe for chemical analysis. In: Doniach HWAS, editor: Synchrotron radiation research. New York: Plenum Press. pp 459-512.
83. Strausak D, Mercer JF, Dieter HH, Stremmel W, Multhaup G. 2001. Copper in disorders with neurological symptoms: Alzheimer's, Menkes, and Wilson diseases. Brain Res Bull 55:175-185.
84. Sullivan DC, Ferrari M. 2004. Nanotechnology and tumor imaging: Seizing an opportunity. Mol Imaging 3:364-369.
85. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. 1991. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
86. Thompson KH, Orvig C. 2003. Boon and bane of metal ions in medicine. Science 300:936-939.
87. Todorich BM, Connor JR. 2004. Redox metals in Alzheimer's disease. Ann N Y Acad Sci 1012:171-178.
88. Twining BS, Fisher NS. 2004. Trophic transfer of trace metals from protozoa to mesozooplankton. Limnol Oceanogr 49:28-39.
89. Twining BS, Baines SB, Fisher NS, Jacobsen C, Maser J. 2003a. Quantification and localization of trace metals in natural plankton cells using a synchrotron X-ray fluorescence microprobe. J De Physique Iv 104:435-438.
90. Twining BS, Baines SB, Fisher NS, Maser J, Vogt S, Jacobsen C, Tovar-Sanchez A, Sanudo-Wilhelmy SA. 2003b. Quantifying trace elements in individual aquatic protist cells with a synchrotron X-ray fluorescence microprobe. Anal Chem 75:3806-3816.
91. Vartsky D, Shilstein S, Bercovich A, Huszar M, Breskin A, Chechik R, Korotinsky S, Malnick SD, Moriel E. 2003. Prostatic zinc and prostate specific antigen: An experimental evaluation of their combined diagnostic value. J Urol 170:2258-2262.
92. Verbi FM, Arruda SC, Rodriguez AP, Perez CA, Arruda MA. 2005. Metal-binding proteins scanning and determination by combining gel electrophoresis, synchrotron radiation X-ray fluorescence and atomic spectrometry. J Biochem Biophys Methods 62:97-109.
93. Vuu K, Xie J, McDonald MA, Bernardo M, Hunter F, Zhang Y, Li K, Bednarski M, Guccione S. 2005. Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging. Bioconjug Chem 16:995-999.
94. Wagner D, Young LS. 2004. Nontuberculous mycobacterial infections: A clinical review. Infection 32:257-270.
95. Wagner D, Maser J, Lai B, Cai Z, Barry CE III, Honer Zu Bentrup K, Russell DG, Bermudez LE. 2005. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J Immunol 174:1491-1500.
96. Wagner D, Maser J, Moric I, Vogt S, Kern WV, Bermudez LE. 2006. Elemental analysis of the Mycobacterium avium phagosome in Balb/c mouse macrophages. Biochem Biophys Res Commun 344:1346-1351.
97. Waisberg M, Joseph P, Hale B, Beyersmann D. 2003. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192:95-117.
98. Walcourt A, Loyevsky M, Lovejoy DB, Gordeuk VR, Richardson DR. 2004. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites. Int J Biochem Cell Biol 36:401-407.
99. Weder JE, Hambley TW, Kennedy BJ, Lay PA, Foran GJ, Rich AM. 2001. Determination of the structures of antiinflammatory copper(II) dimers of indomethacin by multiple-scattering analyses of X-ray absorption fine structure data. Inorg Chem 40:1295-1302.
100. Weinberg ED. 1999. Development of clinical methods of iron deprivation for suppression of neoplastic and infectious diseases. Cancer Invest 17:507-513.
101. Yang L, McRae R, Henary MM, Patel R, Lai B, Vogt S, Fahrni CJ. 2005. Imaging of the intracellular topography of copper with a fluorescent sensor and by synchrotron x-ray fluorescence microscopy. Proc Natl Acad Sci USA 102:11179-11184.
102. Yoon YS, Cho H, Lee JH, Yoon G. 2004. Mitochondrial dysfunction via disruption of complex II activity during iron chelation-induced senescence-like growth arrest of Chang cells. Ann N Y Acad Sci 1011:123-132.
103. Zatta P, Lucchini R, van Rensburg SJ, Taylor A. 2003. The role of metals in neurodegenerative processes: Aluminum, manganese, and zinc. Brain Res Bull 62:15-28.
104. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. 2004. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863-873.
105. Zhang CX, Lippard SJ. 2003. New metal complexes as potential therapeutics. Curr Opin Chem Biol 7:481-489.
106. Zhao R, Planalp RP, Ma R, Greene BT, Jones BT, Brechbiel MW, Torti FM, Torti SV. 2004a. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anticancer iron chelator. Biochem Pharmacol 67:1677-1688.
107. Zhao X, Hilliard LR, Mechery SJ, Wang Y, Bagwe RP, Jin S, Tan W. 2004b. A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. Proc Natl Acad Sci USA 101:15027-15032.